ORIGINAL RESEARCH
Accepted on 13 Jan 2025
Antiangiogenic therapy with recombinant human endostatin may improve blood perfusion of cervical node with necrosis in nasopharyngeal carcinoma patients: A preliminary study by using contrast-enhanced ultrasound
doi 10.3389/fonc.2025.1521762